Invacare Corporation IVC today announced that the United States
Food and Drug Administration (FDA) has found acceptable the Company's
first certification audit relating to the qualification and validation
documentation for equipment and processes at the Taylor Street
manufacturing facility in Elyria, Ohio. This acceptance permits the
Company's Taylor Street facility, which is currently subject to
limitations on production due to an FDA consent decree, to resume
manufacturing and distributing parts, components, accessories and
subassemblies to Invacare facilities other than the Taylor Street or
Corporate facilities, for further manufacturing or to provide service
related to medical devices manufactured at those other Invacare
facilities.
''This is an important step forward
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in